EGFR Exon 20–Altered NSCLC: A Personalized Approach to Improve Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.50
PARP Inhibition in the Treatment of Pancreatic Cancer: Current and Future Perspectives on Personalized Therapy

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
Targeting BTK in CLL: Expert Guidance on Selecting Single-Agent and Combination Therapy

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
New Perspectives in Ovarian Cancer: Current Paradigm and Long-term Benefits of PARPi Therapy

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
A Global Perspective on Biomarkers in Gastrointestinal Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.25
Innovative Therapeutic Approaches for Immune Thrombocytopenia

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Key Data From EHA 2021: A European Expert Perspective

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Key Questions on PARP Inhibitors in Ovarian Cancer: Experts Evaluate the Latest Evidence

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Evolving Strategies Using BTK Inhibitors in CLL: A Selective Approach to Improve Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer (With Italian Subtitles)

Content Format:

Multimedia

Credit Type:

--

Credits:

--
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer (With Spanish Subtitles)

Content Format:

Multimedia

Credit Type:

--

Credits:

--
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer (With French Subtitles)

Content Format:

Multimedia

Credit Type:

--

Credits:

--
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer (With German Subtitles)

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Novel PARP Inhibitor–Based Combinations Targeting Improved Patient Outcomes in Prostate Cancer

Content Format:

Text Module

Credit Type:

--

Credits:

--
Key Studies in Lung Cancer: Independent Conference Coverage of the World Conference on Lung Cancer 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.50
Cancer Conversations™: Experts Discuss the New Immunotherapy Paradigm in Endometrial Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Advances in Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
B-Cell Lymphomas: A European Perspective on Key Trials From ASH 2020

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Global Perspectives on Biomarker-Driven Therapeutic Strategies in Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Improving Diagnosis, Treatment, and QoL for MF-CTCL

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Video Roundtable: Immunotherapy in Endometrial Cancer

Content Format:

Video

Credit Type:

--

Credits:

--
Advances in Endometrial Cancer Therapy: Exploring the Role of Immunotherapy

Content Format:

Text Module

Credit Type:

--

Credits:

--
Current Landscape in Ovarian Cancer: PARP Inhibitors and Targeted Therapy

Content Format:

Text Module

Credit Type:

--

Credits:

--
The Evolution of Antibody–Drug Conjugates in Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
A Global Perspective: An Expert Roundtable on PARP Inhibitors in the Treatment of Metastatic Breast Cancer

Content Format:

Video

Credit Type:

--

Credits:

--
Advances in Immunotherapy for Endometrial Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Current Status and Future Directions for Immunotherapy in Hepatocellular Carcinoma

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Application of the Latest Immuno-Oncology Developments to the Treatment of Urothelial Cancer

Content Format:

Video

Credit Type:

--

Credits:

--
Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Content Format:

Video

Credit Type:

--

Credits:

--
Acute Leukemias: Mastering the Latest Developments in the Absence of Targetable Mutations

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
Improving Outcomes for Patients With CML: The Latest on TKIs and Combination Treatment Approaches

Content Format:

Video

Credit Type:

AMA

Credits:

1.75
Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

Content Format:

Video

Credit Type:

--

Credits:

--
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
New Therapeutic Developments for Relapsed/Refractory Multiple Myeloma

Content Format:

Video

Credit Type:

--

Credits:

--
Focus on Therapy for MET Exon 14 Mutations in Advanced NSCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 1

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Focus on Molecular Testing for MET Exon 14–Skipping Mutations in Advanced NSCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Emerging Therapies and Testing for METex14 in Advanced NSCLC

Content Format:

Text Module

Credit Type:

--

Credits:

--
Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
An Overview of MET Exon 14 Mutation Testing and Treatment in Advanced NSCLC

Content Format:

Video

Credit Type:

--

Credits:

--
An Expert Video Roundtable on Novel Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Content Format:

Video

Credit Type:

--

Credits:

--
An Expert Roundtable Exploring Recent Data in Ovarian Cancer and its Impact on Patient Care

Content Format:

Video

Credit Type:

--

Credits:

--
My Thoughts on New Findings in Lung Cancer From WCLC 2019

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.40